| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 25,800 | 26,400 | 07.01. | |
| 25,800 | 26,400 | 07.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Piper Sandler upgrades Tactile Systems stock to Overweight on growth outlook | 1 | Investing.com | ||
| 04.11.25 | Tactile Systems Surges 39% On Strong Q3 Beat & Guidance Upgrade | 1 | RTTNews | ||
| 04.11.25 | Tactile Systems Technology price target raised to $20 from $14 at Piper Sandler | 6 | Investing.com | ||
| 04.11.25 | Tactile Systems stock rating upgraded to Buy by BTIG on strong results | 2 | Investing.com | ||
| TACTILE SYSTEMS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 03.11.25 | Tactile Systems Technology GAAP EPS of $0.36 beats by $0.19, revenue of $85.8M beats by $6.49M | 5 | Seeking Alpha | ||
| 03.11.25 | TACTILE SYSTEMS TECHNOLOGY INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 03.11.25 | TACTILE SYSTEMS TECHNOLOGY INC - 8-K, Current Report | 6 | SEC Filings | ||
| 28.10.25 | Tactile Systems Technology, Inc.: Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema | 2 | GlobeNewswire (USA) | ||
| 20.10.25 | Tactile Systems Technology, Inc.: Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025 | 1 | GlobeNewswire (USA) | ||
| 05.08.25 | Tactile Systems Technology übertrifft Q2-Prognosen und hebt Ausblick an | 3 | Investing.com Deutsch | ||
| 05.08.25 | Tactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growth | 1 | Seeking Alpha | ||
| 04.08.25 | Tactile Systems Technology GAAP EPS of $0.14 beats by $0.03, revenue of $78.9M beats by $4.97M | 1 | Seeking Alpha | ||
| 04.08.25 | TACTILE SYSTEMS TECHNOLOGY INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 04.08.25 | TACTILE SYSTEMS TECHNOLOGY INC - 8-K, Current Report | 4 | SEC Filings | ||
| 21.07.25 | Tactile Systems Technology, Inc.: Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025 | 1 | GlobeNewswire (USA) | ||
| 06.05.25 | Pre-market Movers: Marin Software, Pasithea Therapeutics, China SXT Pharmaceuticals, Tactile Systems Technology, ThredUp | 712 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green Marin Software Incorporated (MRIN) is up over 141%... ► Artikel lesen | |
| 05.05.25 | Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results | 220 | GlobeNewswire (Europe) | MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic... ► Artikel lesen | |
| 18.02.25 | Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | 281 | GlobeNewswire (Europe) | MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,790 | +0,45 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 293,20 | +0,19 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| DRAEGERWERK | 73,10 | +1,53 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 85,12 | -0,34 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| GERRESHEIMER | 27,700 | -0,72 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen | |
| INTUITIVE SURGICAL | 507,20 | -0,02 % | Is ISRG Stock Still A Buy At $600? | ||
| THERMO FISHER | 528,30 | 0,00 % | BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View | ||
| TELADOC HEALTH | 6,473 | -0,20 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| STRATEC | 22,300 | -1,55 % | Aktien Frankfurt: Dax vorweihnachtlich träge | FRANKFURT (dpa-AFX) - Nach den moderaten Gewinnen am Freitag ist der deutsche Aktienmarkt etwas schwächer in die kurze Handelswoche vor Weihnachten gestartet. Das Geschehen ist von einem deutlich geringeren... ► Artikel lesen | |
| ROKU | 94,03 | -0,40 % | Will Roku Dominate Streaming Stocks in 2026? | ||
| HIMS & HERS HEALTH | 30,270 | -0,33 % | Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization |